Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Dixie Brands Continues with Expansion Plans

DXBRF

VANCOUVER, BC / ACCESSWIRE / February 7, 2019 / Dixie Brands Inc. ("Dixie") (CSE: DIXI.U) (Frankfurt: 0QV) continued this week with the execution of their expansion driven business plan. After announcing last week that Dixie had signed a binding letter of intent with Khiron Life Sciences Corp. in order to distribute their wide range of THC-infused products throughout Latin American, Dixie followed up today with news that it will be entering into a joint venture with Choice Labs in order to bring the Dixie-branded products into Michigan.

Michigan represents a substantial market for Dixie as the state currently hosts one of the largest medical cannabis industries in the United States. More than 300,000 people there utilize medical cannabis and, according to the House Fiscal Agency, the value of the legal cannabis industry in Michigan will grow by approximately $824 million per year. Choice Labs was selected for this joint venture because it not only already operates within Michigan, but also because according to President and Chief Executive Officer of Dixie, Chuck Smith, “Choice Labs has deep roots within the local community.” Through this joint venture, Choice Labs aims to bring into Michigan, Dixie’s expansive lines of tinctures, mints, pressed pills, gummies, topicals and Elixir beverages.

As alluded to earlier, news of this joint venture comes on the heels of other expansion news reported by Dixie just last week. According to reports, Dixie has signed a binding letter of intent with Khiron Life Sciences Corp. in order to bring Dixie’s range of products into Latin America. Just as Choice Labs already has a considerable presence within Michigan, Khiron already has an appreciable presence within Latin America. According to news released by Dixie last Wednesday, Khiron has market access to more than 75% of the total Latin American population. This means that Khiron has market access to more than 465 million individuals living in Mexico and South America.

Canada might be one of the newest and most exciting legal cannabis markets on the globe right now, but the United States continues to be an enormous market with high potential. According to a 2018 report from Grand View Research, the legal cannabis market in the United States will be worth upwards of $146 billion by the year 2025. Dixie continues to believe that the U.S. market has this kind of potential and the company’s continued work towards expanding within the U.S. means that it is well positioned to benefit from any of the substantial potential growth that may take place over the next half-decade.

About Dixie Brands Inc.

Dixie Brands, through its licensed partners, has been formulating award-winning THC (tetrahydrocannabinol) and CBD (cannabidiol) infused products since 2009, and is expecting to double its manufacturing and distribution capabilities in 2019 in the United States as well as expand internationally, including Canada and Latin America. Dixie leads the global industry in the development, packaging design, product innovation and quality control for the commercial production of cannabis-infused products. While the company started with a single flagship product, the Dixie Elixir (a THC-infused soda), it is now one of the industry's most recognized consumer brands, expanding to over 100 products across more than 15 different product categories representing the industry's finest edibles, tinctures, topicals and connoisseur grade extractions, as well as world-class CBD infused wellness products and pet dietary supplements. Dixie's executive team has been instrumental in the formation of the marijuana industry for recreational and medicinal use, serving as founding members on several national regulatory and business-oriented industry organizations.

Global Objective Marketing

Do you want the same kind of exposure that Dixie Brands Inc. is receiving here? Contact Global Objective Marketing and we will produce professionally written press release content for your business and distribute it to any market that you wish to reach. For more information, please visit https://www.globalobjectivemarketing.com/.

This piece was written and distributed by Global Objective Marketing (GOM). All of the information contained within was produced using publicly available information and any opinions about individuals, companies or industries expressed within this release belong solely to GOM. The opinions expressed by GOM should not be considered as complete, accurate, or current investment advice. Any investment decisions made by readers are theirs and theirs alone. To ensure that you are making investment decisions that serve your own best interests, we recommend that you utilize the services of a professional financial planner or advisor. In order to comply with Section 17(b) of the 1933 Securities Act, GOM discloses that it was paid a sum of fifteen hundred dollars CAD to write this content for Dixie Brands Inc.

SOURCE: Global Objective Marketing Ltd.

Tags:


Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today